Cargando…
Novel Guanidine Compound against Multidrug-Resistant Cystic Fibrosis-Associated Bacterial Species
Chronic pulmonary infection is a hallmark of lung disease in cystic fibrosis (CF). Infections dominated by non-fermentative Gram-negative bacilli are particularly difficult to treat and highlight an urgent need for the development of new class of agents to combat these infections. In this work, a sm...
Autores principales: | Saeed, Aamer, Bosch, Alejandra, Bettiol, Marisa, Nossa González, Diana L., Erben, Mauricio Federico, Lamberti, Yanina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100397/ https://www.ncbi.nlm.nih.gov/pubmed/29751676 http://dx.doi.org/10.3390/molecules23051158 |
Ejemplares similares
-
Antigiardial Activity of Novel Guanidine Compounds
por: Stevens, Andrew J., et al.
Publicado: (2022) -
First time identification of Pandoraea sputorum from a patient with cystic fibrosis in Argentina: a case report
por: Martina, Pablo F., et al.
Publicado: (2017) -
Mechanism of Action of Isopropoxy Benzene Guanidine against Multidrug-Resistant Pathogens
por: Li, Jie, et al.
Publicado: (2022) -
In vitro Antibacterial Activity of Isopropoxy Benzene Guanidine Against Multidrug-Resistant Enterococci
por: Zhang, Xiufeng, et al.
Publicado: (2019) -
Multidrug-Resistant Bacteria in Children and Adolescents with Cystic Fibrosis
por: Fainardi, Valentina, et al.
Publicado: (2022)